Related references
Note: Only part of the references are listed.Effects of pentoxifylline and tocopherol on an osteoradionecrosis animal model
Mi Hyun Seo et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2020)
Treatment ofCOVID-19 with pentoxifylline: Could it be a potential adjuvant therapy?
Farnoosh Seirafianpour et al.
DERMATOLOGIC THERAPY (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
SARS-CoV-2: a storm is raging
Savannah F. Pedersen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Extensive protein expression changes induced by pamidronate in RAW 264.7 cells as determined by IP-HPLC
Sang Shin Lee et al.
PEERJ (2020)
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Bo Diao et al.
FRONTIERS IN IMMUNOLOGY (2020)
The first, holistic immunological model of COVID-19: Implications for prevention, diagnosis, and public health measures
Paolo Maria Matricardi et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2020)
Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole
James J. DiNicolantonio et al.
MEDICAL HYPOTHESES (2020)
Pentoxifylline and complicated COVID-19: A pathophysiologically based treatment proposal
Stelios F. Assimakopoulos et al.
MEDICAL HYPOTHESES (2020)
Treatment for COVID-19: An overview
Cristina Stasi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies
Elahe Seyed Hosseini et al.
VIROLOGY (2020)
Can pentoxifylline and similar xanthine derivatives find a niche in COVID-19 therapeutic strategies? A ray of hope in the midst of the pandemic
Faezeh Monji et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19
Valente Maldonado et al.
MEDICAL HYPOTHESES (2020)
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Miriam Merad et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Potential Use of Pentoxifylline in Cancer Therapy
Grzegorz Golunski et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2018)
Pentoxifylline Alone or in Combination with Gentamicin or Vancomycin Inhibits Live Microbe-Induced Proinflammatory Cytokine Production in Human Cord Blood and Cord Blood Monocytes In Vitro
Esther M. Speer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Sepsis and Oxidative Stress in the Newborn: From Pathogenesis to Novel Therapeutic Targets
Chiara Poggi et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
In vitro protein expression changes in RAW 264.7 cells and HUVECs treated with dialyzed coffee extract by immunoprecipitation high performance liquid chromatography
Cheol Soo Yoon et al.
SCIENTIFIC REPORTS (2018)
Pentoxifylline decreases post-operative intra-abdominal adhesion formation in an animal model
Ya-Lin Yang et al.
PEERJ (2018)
Differential protein expression in the secretory fluids of maxillary sinusitis and maxillary retention cyst
Soung Min Kim et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2017)
Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling
Yan Wang et al.
LIFE SCIENCES (2017)
Pentoxifylline Regulates Plasminogen Activator Inhibitor-1 Expression and Protein Kinase A Phosphorylation in Radiation-Induced Lung Fibrosis
Jong-Geol Lee et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Effect of pentoxifylline on healing of segmental bone defects and angiogenesis
Gokhan Cakmak et al.
ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA (2015)
Effects of pentoxifylline and alpha lipoic acid on methotrexate-induced damage in liver and kidney of rats
Ilkay Armagan et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2015)
Pentoxifylline Therapy for Late-Onset Sepsis in Preterm Infants A Randomized Controlled Trial
Abd Elazeez Shabaan et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2015)
Macrophages and bisphosphonate-related osteonecrosis of the jaw (BRONJ): evidence of local immunosuppression of macrophages in contrast to other infectious jaw diseases
Sebastian Hoefert et al.
CLINICAL ORAL INVESTIGATIONS (2015)
Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway
Mohammad Zahid Kamran et al.
BIOMEDICINE & PHARMACOTHERAPY (2013)
Pentoxifylline Improves Nonalcoholic Steatohepatitis: A Randomized Placebo-Controlled Trial
Claudia O. Zein et al.
HEPATOLOGY (2011)
COMPLETE RESTORATION OF REFRACTORY MANDIBULAR OSTEORADIONECROSIS BY PROLONGED TREATMENT WITH A PENTOXIFYLLINE-TOCOPHEROL-CLODRONATE COMBINATION (PENTOCLO): A PHASE II TRIAL
Sylvie Delanian et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Osteoradionecrosis
Karla O'Dell et al.
ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA (2011)
Hypoxia Inducible Factor 1α Signaling in Fractionated Radiation-Induced Lung Injury: Role of Oxidative Stress and Tissue Hypoxia
Z. N. Rabbani et al.
RADIATION RESEARCH (2010)
Effects of pentoxifylline and its metabolites on platelet aggregation in whole blood from healthy humans
Marie Magnusson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Prevention and treatment of functional and structural radiation injury in the rat heart by pentoxifylline and alpha-tocopherol
Marjan Boerma et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Effects of pentoxifylline on differentiation, maturation, and function of human CD14(+) monocyte-derived dendritic cells
Rongxin Zhang et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: A phase II trial
S Delanian et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2005)
Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor
SL Lin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Enhancement of recombinant human bone morphogenetic protein-2 (rhBMP-2)-induced new bone formation by concurrent treatment with parathyroid hormone and a phosphodiesterase inhibitor, pentoxifylline
H Horiuchi et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2004)
Pentoxifylline in the treatment of radiation-induced fibrosis
P Okunieff et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway
S Delanian et al.
RADIOTHERAPY AND ONCOLOGY (2004)
Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis
S Delanian et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Modulation of radiation-induced tumour necrosis factor α (TNF-α) expression in the lung tissue by pentoxifylline
CE Rübe et al.
RADIOTHERAPY AND ONCOLOGY (2002)
In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine
B Horvath et al.
CLINICAL NEUROPHARMACOLOGY (2002)
Effects of pentoxifylline, pentifylline and γ-interferon on proliferation, differentiation, and matrix synthesis of human renal fibroblasts
F Strutz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2000)
Share Paper
